U

ADAMA Health-Tech Accelerator

Corporate Accelerator Israel Founded 2019
Last Update Nov 12, 2020

ADAMA Health-Tech Accelerator News

3 articles
Jul 14, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- ADAMA Ltd. (the "Company") (SZSE: 000553), today provided an estimate regarding its financial performance for the first half of 2025. The...
ADAMA Ltd. has provided an estimate of its financial performance for the first half of 2025, showing a positive impact from its Fight Forward strategic transformation plan. The company expects flat sales compared to the first half of 2024, with volume growth offsetting lower prices. ADAMA anticipates an increase in adjusted EBITDA and net profit, with an expected adjusted net profit between USD 47 million to 54 million, compared to a loss in the previous year. The improvement is attributed to higher gross profit margins and lower costs. The company also expects a narrowed reported net loss. These results are preliminary and unaudited, with final financial statements expected on August 26, 2025.
Mar 13, 2025 · www.prnewswire.com
growth-positive
/PRNewswire/ -- ADAMA Ltd. (the "Company") (SZSE 000553), today reported its financial results for the fourth quarter and full year ended December 31, 2024....
ADAMA Ltd. reported its financial results for Q4 and the full year of 2024, highlighting the initial success of its Fight Forward strategic transformation plan. Despite a 2% decrease in Q4 sales, the company saw a 14% increase in adjusted gross profit and a 45% rise in adjusted EBITDA. The plan focuses on optimizing financial management, streamlining operations, and focusing on value innovation. ADAMA launched several new products and continued to enhance its sustainability efforts. The company improved its cash flow and reduced its net loss, indicating positive momentum for future growth.
Oct 27, 2020 · www.jpost.com
growth-positive
https://www.jpost.com/health-science/tech-accelerator-showcasing-creative-medical-solutions-wraps-up-in-ashdod-647102
The Adama Accelerator for Medical Entrepreneurship, organized by Adama, has concluded its program showcasing twelve projects aimed at finding innovative solutions to medical challenges. The projects include early detection and diagnosis of viruses like COVID-19, AI-based detection of fetal distress, and a smartphone app for muscle stimulation. The accelerator provided mentorship and guidance to the participants, helping them develop business models, marketing strategies, and pitches to potential investors. The final event was streamed live to hospital managers, employees, and potential investors. Adama, a leading generic crop protection company, supports the accelerator as part of its commitment to technology, entrepreneurship, and innovation. The company believes that the program will contribute to the development of new projects that benefit the medical world and hospital patients.
PartnersInvestment